The company said that while it regrets Bisaro’s decision to leave, it is confident that the departure will not have a negative effect on US or international operations and will not delay or hamper the nearly completed integration of Pliva, the Croatia-based generics company Barr acquired in 2006.
“The operations portion of our business that had previously reported to Paul will now report directly to me, and the reporting structure within the organization has now been appropriately modified,” said Bruce Downey.
“Since the acquisition of Pliva last year, we have in place the multi-disciplinary teams that have been managing the day-to-day integration of our two organizations, and we have met many of the major integration milestones,” Mr Downey continued. “I expect that these integration activities will continue and that we will fully integrate both organizations on schedule.”